Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists

Latest Finepoint Capital LP Stock Portfolio

$389Million

Equity Portfolio Value
Last Reported on: 14 May, 2024

About Finepoint Capital LP and it’s 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Finepoint Capital LP reported an equity portfolio of $389.9 Millions as of 31 Mar, 2024.

The top stock holdings of Finepoint Capital LP are LBRDA, SWTX, ASND. The fund has invested 27.7% of it's portfolio in LIBERTY BROADBAND CORP and 7.5% of portfolio in SPRINGWORKS THERAPEUTICS INC.

The fund managers got completely rid off AMICUS THERAPEUTICS INC (FOLD), HOME PLATE ACQUISITION CORP (HPLT) and MORPHIC HOLDING INC (MORF) stocks. They significantly reduced their stock positions in MOONLAKE IMMUNOTHERAPEUTICS (MLTX) and CYTOKINETICS INC (CYTK). Finepoint Capital LP opened new stock positions in ARGENX SE (ARGX), EYEPOINT PHARMACEUTICALS INC (EYPT) and MONEYHERO LIMITED. The fund showed a lot of confidence in some stocks as they added substantially to LIBERTY BROADBAND CORP (LBRDA), PROTHENA CORP PLC (PRTA) and TRAVERE THERAPEUTICS INC (TVTX).

New Buys

Ticker$ Bought
ARGENX SE19,686,000
EYEPOINT PHARMACEUTICALS INC13,571,900
DISH NETWORK CORPORATION13,450,500
MONEYHERO LIMITED108,474

New stocks bought by Finepoint Capital LP

Additions to existing portfolio by Finepoint Capital LP

Reductions

Ticker% Reduced
MOONLAKE IMMUNOTHERAPEUTICS-59.67
CYTOKINETICS INC-44.86

Finepoint Capital LP reduced stake in above stock

Sold off

Ticker$ Sold
AMICUS THERAPEUTICS INC-21,129,300
MORPHIC HOLDING INC-14,349,200
ROSS ACQUISITION CORP II-24,621
HOME PLATE ACQUISITION CORP-20,014,200

Finepoint Capital LP got rid off the above stocks

Current Stock Holdings of Finepoint Capital LP

Last Reported on: 14 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions
ACADACADIA PHARMACEUTICALS INC3.98840,45315,540,000ADDED9.2
ARGXARGENX SE5.0550,00019,686,000NEW
ARVNARVINAS INC5.71539,10022,254,000ADDED6.82
ASNDASCENDIS PHARMA A/S6.81175,67226,556,300ADDED7.27
CDAQCOMPASS DIGITAL ACQUISITION CORP0.01459,90642,311UNCHANGED0.00
CNDACONCORD ACQUISITION CORP II0.01408,33345,447UNCHANGED0.00
CVIICHURCHILL CAPITAL CORP VII0.04548,000175,360UNCHANGED0.00
CYTKCYTOKINETICS INC4.28238,04616,689,400REDUCED-44.86
DISHDISH NETWORK CORPORATION3.4518,300,00013,450,500NEW
EYPTEYEPOINT PHARMACEUTICALS INC3.48656,60013,571,900NEW
FLAGCALIDI BIOTHERAPEUTICS INC0.02125,00070,625UNCHANGED0.00
FLAGCALIDI BIOTHERAPEUTICS INC0.01655,20034,070UNCHANGED0.00
FOLDAMICUS THERAPEUTICS INC0.000.000.00SOLD OFF-100
GATEMARBLEGATE ACQUISITION CORP0.00735,0008,232UNCHANGED0.00
GLPGGALAPAGOS NV4.16503,75916,221,000ADDED9.83
HPLTHOME PLATE ACQUISITION CORP0.000.000.00SOLD OFF-100
IVCPSWIFTMERGE ACQUISITION CORP0.01490,00027,391UNCHANGED0.00
LBRDALIBERTY BROADBAND CORP27.681,886,260107,951,000ADDED922
MLTXMOONLAKE IMMUNOTHERAPEUTICS4.65360,91618,128,800REDUCED-59.67
MORFMORPHIC HOLDING INC0.000.000.00SOLD OFF-100
PRTAPROTHENA CORP PLC2.56402,4009,967,450ADDED15.2
RLAYRELAY THERAPEUTICS INC3.171,490,17012,368,400ADDED13.07
ROSSROSS ACQUISITION CORP II0.000.000.00SOLD OFF-100
RVMDREVOLUTION MEDICINES INC5.60677,10021,822,900ADDED9.72
SLDBSOLID BIOSCIENCES INC3.28961,25112,803,900UNCHANGED0.00
SRPTSAREPTA THERAPEUTICS INC5.26158,45720,513,800ADDED9.01
SWTXSPRINGWORKS THERAPEUTICS INC7.48592,52829,164,200ADDED6.39
TVTXTRAVERE THERAPEUTICS INC3.261,649,22012,715,500ADDED14.9
MONEYHERO LIMITED0.03895,000108,474NEW
YS BIOPHARMA CO LTD0.01489,99924,990UNCHANGED0.00